DAWES KAREN A
Insider CIK 1261506 · DEPO Director · BRNS Director · RGEN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 18,604 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 19,197 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 19,516 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 20,174 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 34,328 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer | 2026-09-09 | 2026-09-09 | 1,700 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 20,174 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 19,516 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 19,197 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 18,604 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 34,328 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer | 2026-09-09 | 2026-09-09 | 1,700 | — | — | 0 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2026-05-14 | 2026-05-18 | 2,239 | — | $0 | 2,239 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2026-05-14 | 2026-05-18 | 995 | — | $0 | 92,816 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-12-17 | 2025-12-18 | 275 | $161.00 | $44.3K | 91,821 | SEC↗ |
| BRNS Barinthus Biotherapeutics | A Award deriv | 2025-06-10 | 2025-06-11 | 20,174 | — | $0 | 20,174 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2025-05-15 | 2025-05-19 | 1,800 | — | $0 | 1,800 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2025-05-15 | 2025-05-19 | 973 | — | $0 | 92,096 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2024-06-14 | 2024-06-14 | 2,953 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2024-06-14 | 2024-06-14 | 2,953 | $67.71 | $199.9K | 88,170 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2024-05-16 | 2024-05-20 | 1,576 | — | $0 | 1,576 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2024-05-16 | 2024-05-20 | 803 | — | $0 | 88,170 | SEC↗ |
| BRNS Barinthus Biotherapeutics | A Award deriv | 2024-05-10 | 2024-05-14 | 19,516 | — | $0 | 19,516 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2024-02-27 | 2024-02-28 | 4,626 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2024-02-27 | 2024-02-28 | 4,626 | $42.07 | $194.6K | 88,367 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-02-27 | 2024-02-28 | 1,000 | $193.35 | $193.3K | 87,367 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2023-08-29 | 2023-08-30 | 7,392 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2023-08-29 | 2023-08-30 | 7,392 | $18.12 | $133.9K | 84,591 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2023-08-29 | 2023-08-30 | 850 | $171.38 | $145.7K | 83,741 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2023-05-18 | 2023-05-22 | 1,730 | — | $0 | 1,730 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2023-05-18 | 2023-05-22 | 798 | — | $0 | 77,199 | SEC↗ |
| VACC Vaccitech plc | A Award deriv | 2023-05-11 | 2023-05-12 | 19,197 | — | $0 | 19,197 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-09 | 2022-09-09 | 775 | $227.17 | $176.1K | 76,401 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2022-05-26 | 2022-05-31 | 1,565 | — | $0 | 1,565 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2022-05-26 | 2022-05-31 | 644 | — | $0 | 77,176 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-05-25 | 2022-05-26 | 7,677 | $150.19 | $1.15M | 80,994 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-05-25 | 2022-05-26 | 742 | $152.84 | $113.4K | 76,532 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-05-25 | 2022-05-26 | 1,875 | $152.14 | $285.3K | 77,274 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-05-25 | 2022-05-26 | 1,845 | $151.14 | $278.9K | 79,149 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-05-25 | 2022-05-26 | 2,576 | $149.18 | $384.3K | 88,671 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-11-10 | 2021-11-12 | 4,783 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 255 | $269.94 | $68.8K | 91,261 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 349 | $267.75 | $93.4K | 91,516 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 486 | $266.72 | $129.6K | 91,865 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 488 | $265.27 | $129.5K | 92,351 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 336 | $264.21 | $88.8K | 92,839 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 1,038 | $262.28 | $272.2K | 94,294 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 236 | $261.10 | $61.6K | 95,332 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 462 | $259.75 | $120.0K | 95,568 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-11-10 | 2021-11-12 | 4,783 | $26.12 | $124.9K | 96,030 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 14 | $271.28 | $3.8K | 91,247 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-10 | 2021-11-12 | 1,119 | $263.23 | $294.6K | 93,175 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-02 | 2021-11-04 | 446 | $301.97 | $134.7K | 92,886 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-02 | 2021-11-04 | 532 | $303.48 | $161.5K | 92,354 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-02 | 2021-11-04 | 124 | $304.23 | $37.7K | 92,230 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-02 | 2021-11-04 | 700 | $305.91 | $214.1K | 91,530 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-02 | 2021-11-04 | 283 | $306.49 | $86.7K | 91,247 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-02 | 2021-11-04 | 64 | $299.02 | $19.1K | 93,583 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-02 | 2021-11-04 | 251 | $301.20 | $75.6K | 93,332 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-14 | 2021-09-15 | 101 | $294.06 | $29.7K | 93,782 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-14 | 2021-09-15 | 13 | $290.02 | $3.8K | 93,908 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-14 | 2021-09-15 | 25 | $292.34 | $7.3K | 93,883 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-14 | 2021-09-15 | 27 | $295.82 | $8.0K | 93,647 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-14 | 2021-09-15 | 108 | $295.02 | $31.9K | 93,674 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-09-01 | 2021-09-02 | 3,459 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-01 | 2021-09-02 | 1,107 | $284.64 | $315.1K | 94,772 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-01 | 2021-09-02 | 661 | $283.56 | $187.4K | 95,879 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-01 | 2021-09-02 | 405 | $282.53 | $114.4K | 96,540 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-01 | 2021-09-02 | 851 | $285.44 | $242.9K | 93,921 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-01 | 2021-09-02 | 196 | $281.68 | $55.2K | 96,945 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-01 | 2021-09-02 | 239 | $280.27 | $67.0K | 97,141 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-09-01 | 2021-09-02 | 3,459 | $38.76 | $134.1K | 97,380 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-18 | 2021-08-19 | 78 | $260.91 | $20.4K | 93,961 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-18 | 2021-08-19 | 388 | $259.93 | $100.9K | 94,039 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-18 | 2021-08-19 | 634 | $258.91 | $164.1K | 94,427 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-18 | 2021-08-19 | 302 | $257.66 | $77.8K | 95,061 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-18 | 2021-08-19 | 40 | $262.31 | $10.5K | 93,921 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-17 | 2021-08-19 | 194 | $256.43 | $49.7K | 95,363 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-17 | 2021-08-19 | 2,231 | $255.07 | $569.1K | 95,557 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-17 | 2021-08-19 | 8,580 | $254.09 | $2.18M | 97,788 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-17 | 2021-08-19 | 4,665 | $253.34 | $1.18M | 106,368 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-17 | 2021-08-19 | 920 | $251.92 | $231.8K | 111,033 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-08-17 | 2021-08-19 | 924 | $251.15 | $232.1K | 111,953 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-20 | 2021-07-22 | 614 | $203.11 | $124.7K | 112,877 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-20 | 2021-07-22 | 2,877 | $202.29 | $582.0K | 113,491 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-20 | 2021-07-22 | 806 | $201.37 | $162.3K | 116,368 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-20 | 2021-07-22 | 288 | $200.01 | $57.6K | 117,174 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-07-13 | 2021-07-15 | 2,929 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-07-13 | 2021-07-22 | 2,929 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-07-13 | 2021-07-15 | 2,929 | $41.19 | $120.6K | 118,982 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-13 | 2021-07-15 | 1,520 | $202.23 | $307.4K | 117,462 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-13 | 2021-07-22 | 444 | $203.09 | $90.2K | 117,467 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-13 | 2021-07-22 | 630 | $202.29 | $127.4K | 117,911 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-13 | 2021-07-22 | 441 | $201.27 | $88.8K | 118,541 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-07-13 | 2021-07-22 | 2,929 | $41.19 | $120.6K | 118,982 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-07-13 | 2021-07-22 | 5 | $204.02 | $1.0K | 117,462 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2021-05-13 | 2021-05-17 | 1,522 | — | $0 | 1,522 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2021-05-13 | 2021-05-17 | 604 | — | $0 | 116,053 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-05-11 | 2021-05-13 | 15,000 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-05-11 | 2021-05-13 | 15,000 | $3.22 | $48.3K | 115,734 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-11 | 2021-05-13 | 285 | $176.85 | $50.4K | 115,449 | SEC↗ |
| VACC Vaccitech plc | P Buy | 2021-05-04 | 2021-05-06 | 1,700 | $17.00 | $28.9K | 1,700 | SEC↗ |
| VACC Vaccitech plc | A Award deriv | 2021-04-29 | 2021-05-04 | 34,328 | — | $0 | 34,328 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-06-18 | 2020-06-22 | 8,217 | $115.76 | $951.2K | 103,302 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-06-18 | 2020-06-22 | 5,243 | $114.49 | $600.3K | 111,519 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-06-18 | 2020-06-22 | 2,568 | $116.56 | $299.3K | 100,734 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-06-18 | 2020-06-22 | 2,677 | $113.58 | $304.1K | 116,762 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-20 | 2020-05-21 | 43 | $136.98 | $5.9K | 119,903 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-20 | 2020-05-21 | 10 | $135.91 | $1.4K | 119,946 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-20 | 2020-05-21 | 282 | $139.40 | $39.3K | 119,621 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-20 | 2020-05-21 | 182 | $140.29 | $25.5K | 119,439 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-19 | 122 | $139.32 | $17.0K | 120,293 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-19 | 712 | $135.76 | $96.7K | 120,844 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-19 | 80 | $142.45 | $11.4K | 119,956 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-19 | 77 | $141.45 | $10.9K | 120,036 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-19 | 180 | $140.62 | $25.3K | 120,113 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-19 | 269 | $138.60 | $37.3K | 120,415 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-19 | 160 | $136.92 | $21.9K | 120,684 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-21 | 180 | $140.62 | $25.3K | 120,113 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-21 | 80 | $142.45 | $11.4K | 119,956 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-21 | 77 | $141.45 | $10.9K | 120,036 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-21 | 122 | $139.32 | $17.0K | 120,293 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-21 | 269 | $138.60 | $37.3K | 120,415 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-21 | 160 | $136.92 | $21.9K | 120,684 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-18 | 2020-05-21 | 712 | $135.76 | $96.7K | 120,844 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2020-05-13 | 2020-05-19 | 1,761 | — | $0 | 1,761 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2020-05-13 | 2020-05-21 | 1,761 | — | $0 | 1,761 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2020-05-13 | 2020-05-19 | 722 | — | $0 | 121,556 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2020-05-13 | 2020-05-21 | 722 | — | $0 | 121,556 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | S Sale | 2020-05-08 | 2020-05-11 | 15,834 | $0.79 | $12.5K | 84,589 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-04-21 | 2020-04-22 | 11,800 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-04-21 | 2020-05-21 | 11,800 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-04-21 | 2020-04-22 | 11,800 | $3.30 | $38.9K | 120,834 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-04-21 | 2020-05-21 | 11,800 | $3.30 | $38.9K | 120,834 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-04-20 | 2020-04-22 | 8,200 | — | $0 | 11,800 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-04-20 | 2020-05-21 | 8,200 | — | $0 | 11,800 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-04-20 | 2020-04-22 | 8,998 | $104.42 | $939.6K | 109,034 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-04-20 | 2020-04-22 | 3,202 | $104.98 | $336.1K | 118,032 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-04-20 | 2020-04-22 | 8,200 | $3.30 | $27.1K | 121,234 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-04-20 | 2020-05-21 | 8,200 | $3.30 | $27.1K | 121,234 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-04-20 | 2020-05-21 | 3,202 | $104.98 | $336.1K | 118,032 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-04-20 | 2020-05-21 | 8,998 | $104.42 | $939.6K | 109,034 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-21 | 2020-02-24 | 300 | $101.06 | $30.3K | 116,734 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-21 | 2020-02-24 | 945 | $99.85 | $94.4K | 115,789 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-21 | 2020-02-24 | 906 | $99.12 | $89.8K | 114,883 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-21 | 2020-02-24 | 1,849 | $97.52 | $180.3K | 113,034 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2019-06-17 | 2019-06-19 | 20,000 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2019-06-17 | 2019-06-19 | 20,000 | $4.96 | $99.2K | 118,329 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-06-17 | 2019-06-19 | 1,295 | $77.35 | $100.2K | 117,034 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | S Sale | 2019-06-13 | 2019-06-14 | 12,500 | $3.18 | $39.8K | 100,423 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2019-05-15 | 2019-05-17 | 2,953 | — | $0 | 2,953 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2019-05-15 | 2019-05-17 | 1,292 | — | $0 | 98,329 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise deriv | 2019-05-08 | 2019-05-09 | 31,250 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise | 2019-05-08 | 2019-05-09 | 31,250 | — | $0 | 112,923 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | A Award | 2019-05-07 | 2019-05-09 | 39,584 | — | $0 | 81,673 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise deriv | 2018-12-03 | 2018-12-04 | 15,000 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | M Exercise | 2018-12-03 | 2018-12-04 | 15,000 | $1.49 | $22.4K | 50,510 | SEC↗ |
| ASRT Assertio Therapeutics, Inc | S Sale | 2018-12-03 | 2018-12-04 | 8,421 | $4.84 | $40.8K | 42,089 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2018-05-16 | 2018-05-17 | 4,626 | — | $0 | 4,626 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2018-05-16 | 2018-05-17 | 2,080 | — | $0 | 97,037 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2018-05-11 | 2018-05-15 | 20,000 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2018-05-11 | 2018-05-15 | 20,000 | $41.80 | $836.0K | 94,957 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2018-05-11 | 2018-05-15 | 20,000 | $5.08 | $101.6K | 114,957 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2018-05-08 | 2018-05-10 | 31,250 | — | $0 | 31,250 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2017-08-15 | 2017-08-16 | 19,512 | — | $0 | 19,512 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2017-05-18 | 2017-05-22 | 3,459 | — | $0 | 3,459 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2017-05-18 | 2017-05-22 | 1,714 | — | $0 | 94,957 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2017-03-21 | 2017-03-22 | 20,000 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2017-03-21 | 2017-03-22 | 2,521 | $34.12 | $86.0K | 93,243 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2017-03-21 | 2017-03-22 | 20,000 | $4.29 | $85.8K | 95,764 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2016-07-14 | 2016-07-15 | 20,000 | — | $0 | 75,764 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2016-06-27 | 2016-06-28 | 15,000 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2016-06-27 | 2016-06-28 | 1,982 | $23.46 | $46.5K | 55,764 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2016-06-27 | 2016-06-28 | 15,000 | $3.10 | $46.5K | 57,746 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2016-05-18 | 2016-05-20 | 3,131 | — | $0 | 3,131 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2016-05-18 | 2016-05-20 | 7,669 | — | $0 | 7,669 | SEC↗ |
| DEPO DEPOMED INC | F Tax w/h | 2016-05-12 | 2016-05-13 | 734 | $17.52 | $12.9K | 12,867 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2016-05-11 | 2016-05-13 | 4,783 | — | $0 | 4,783 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2016-05-11 | 2016-05-13 | 2,505 | — | $0 | 42,746 | SEC↗ |
| DEPO DEPOMED INC | F Tax w/h | 2015-12-01 | 2015-12-03 | 1,198 | $19.00 | $22.8K | 10,665 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2015-11-10 | 2015-11-12 | 1,000 | $26.70 | $26.7K | 40,241 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2015-05-21 | 2015-05-26 | 2,929 | — | $0 | 2,929 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2015-05-21 | 2015-05-26 | 1,498 | — | $0 | 39,241 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2015-05-12 | 2015-05-13 | 7,857 | — | $0 | 7,857 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2015-05-12 | 2015-05-13 | 2,936 | — | $0 | 2,936 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2014-12-01 | 2014-12-12 | 9,852 | — | $0 | 9,852 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2014-12-01 | 2014-12-12 | 3,863 | — | $0 | 3,863 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2014-05-15 | 2014-05-19 | 7,392 | — | $0 | 7,392 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2014-05-15 | 2014-05-19 | 3,863 | — | $0 | 37,743 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2013-12-10 | 2013-12-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RGEN REPLIGEN CORP | P Buy | 2013-06-21 | 2013-06-21 | 1,000 | $7.70 | $7.7K | 33,880 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2013-05-09 | 2013-05-16 | 5,342 | — | $0 | 32,880 | SEC↗ |
| DEPO DEPOMED INC | P Buy | 2013-03-06 | 2013-03-06 | 2,000 | $5.96 | $11.9K | 8,000 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2012-12-04 | 2012-12-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2012-05-24 | 2012-06-20 | 11,038 | — | $0 | 27,538 | SEC↗ |